MedTrace Logo

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

NCT00593229 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2013-06-19

No results posted yet for this study

Summary

This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA) annually from pediatric patients with thrombotic mcroangiopathy

Conditions

Sponsors & Collaborators

  • Children's Hospital of Philadelphia

    collaborator OTHER

  • Mario Negri Institute for Pharmacological Research

    collaborator OTHER

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER

  • University of Virginia

    collaborator OTHER

  • Montreal Children's Hospital of the MUHC

    collaborator OTHER

  • University of Utah

    collaborator OTHER

  • Stollery Children's Hospital

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Northwell Health

    lead OTHER

Principal Investigators

  • Howard Trachtman, MD · Schneider Children's Hospital

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00593229 on ClinicalTrials.gov